-

New Portfolio of Chromatography and Mass Spectrometry Consumables Assures Quality and Performance

Thermo Scientific SureSTART consumables portfolio is designed for higher performance requirements, while meeting customer budgets

LANGERWEHE, Germany--(BUSINESS WIRE)--A new collection of caps, vials, inserts, kits, well plates and mats improves analytical performance and sample security for chromatography and mass spectrometry users in routine and research laboratories, across a diverse range of sectors such as pharma, biopharma, clinical, food, environmental and academia.

The Thermo Scientific SureSTART portfolio is compatible with all add-on and chromatography autosamplers, allowing analysts to use the new portfolio regardless of the instrument vendor. The new collection provides sample security and low compound adsorption, even for challenging, low-level analytes. This provides laboratories with the needed confidence in their results every time, and reduces the time needed for reviewing background peaks or identifying analytes that have shifted retention times. The SureSTART line draws from existing products that have been successful in the market for more than 40 years and improves the product experience—providing precise and consistent measurements between different vials and different lots.

“As a trusted provider of vials, closures and well plates, we continue to innovate to offer laboratories the improved flexibility and assurance needed to meet analytical requirements,” said Detlev Lennartz, product manager, sample handling, chromatography and mass spectrometry, Thermo Fisher. “SureSTART consumables are built from high-quality materials that meet both the performance and price requirements of our customers, providing the confidence they need to analyze challenging analytes. Additionally, the new collection is fully compatible with GC, GC-MS, LC and LC-MS analytical instruments and includes three performance levels to help laboratories choose the right product for their experimental needs.”

To learn more about the SureSTART collection, please visit www.thermofisher.com/surestart.

About Thermo Fisher Scientific

Thermo Fisher Scientific Inc. is the world leader in serving science, with annual revenue of approximately $40 billion. Our Mission is to enable our customers to make the world healthier, cleaner and safer. Whether our customers are accelerating life sciences research, solving complex analytical challenges, increasing productivity in their laboratories, improving patient health through diagnostics or the development and manufacture of life-changing therapies, we are here to support them. Our global team delivers an unrivaled combination of innovative technologies, purchasing convenience and pharmaceutical services through our industry-leading brands, including Thermo Scientific, Applied Biosystems, Invitrogen, Fisher Scientific, Unity Lab Services, Patheon and PPD. For more information, please visit www.thermofisher.com.

Contacts

Media:
Laura Bright
Thermo Fisher Scientific
+1 562-335-8318
laura.bright@thermofisher.com

Janice Foley
BioStrata
+1 617-823-5555
jfoley@biostratamarketing.com

Thermo Fisher

NYSE:TMO
Details
Headquarters: Waltham, Massachusetts
CEO: Marc N. Casper
Employees: 100,000
Organization: PUB
Revenues: $40 Billion (2021)

Release Summary
Thermo Scientific SureSTART consumables portfolio is designed for higher performance requirements, while meeting customer budgets.
Release Versions

Contacts

Media:
Laura Bright
Thermo Fisher Scientific
+1 562-335-8318
laura.bright@thermofisher.com

Janice Foley
BioStrata
+1 617-823-5555
jfoley@biostratamarketing.com

More News From Thermo Fisher

Thermo Fisher Scientific Expands Orbitrap Innovation Across Research, Biopharma and Applied Testing at ASMS 2026

WALTHAM, Mass.--(BUSINESS WIRE)--Thermo Fisher Scientific Inc., the world leader in serving science, today expanded its suite of Thermo Scientific™ Orbitrap™ mass spectrometry platforms, AI-enabled software and integrated workflows at the American Society for Mass Spectrometry (ASMS) Conference. Across research, biopharma and applied testing, scientists face increasingly complex samples, expanding data sets and greater pressure to deliver confident answers faster. Thermo Fisher helps solve that...

Thermo Fisher Scientific Unveils Next-generation Innovations at ASMS 2026 to Accelerate the Path from Drug Discovery to New Therapies

WALTHAM, Mass.--(BUSINESS WIRE)--Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, today announced the Thermo Scientific™ Orbitrap™ Tribrid™ Apex and Thermo Scientific™ Orbitrap™ Excedion™ mass spectrometers will be showcased at the American Society for Mass Spectrometry (ASMS) Conference. As scientific discovery expands into more complex applications—from advanced proteomics and multiomics to biologics and genetic medicines—researchers and drug developers face inc...

Thermo Fisher Scientific Announces Quarterly Dividend

WALTHAM, Mass.--(BUSINESS WIRE)--Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, today announced that its Board of Directors authorized a quarterly cash dividend of $0.47 per common share, payable on July 15, 2026, to shareholders of record as of June 15, 2026. About Thermo Fisher Scientific Thermo Fisher Scientific Inc. is the world leader in serving science, with annual revenue over $45 billion. Our Mission is to enable our customers to make the world healthier...
Back to Newsroom